Dexmedetomidine use and mortality in mechanically ventilated patients with severe burns: A cohort study using a national inpatient database in Japan.

Burns : Journal of the International Society for Burn Injuries
Yuki EnomotoNanako Tamiya

Abstract

Dexmedetomidine is an alpha 2-adrenergic receptor agonist. Apart from its sedative effects, dexmedetomidine can potentially reduce mortality through its anti-inflammatory effect. However, the impact of dexmedetomidine on in-hospital outcomes of patients with severe burns remains unclear. Therefore, we aimed to elucidate the association between dexmedetomidine use and mortality in mechanically ventilated patients with severe burns, using a Japanese nationwide database of in-hospital patients. We included adults with severe burns (burn index ≥ 10) who were registered in the Japanese Diagnosis Procedure Combination national inpatient database from 2010 to 2018, started mechanical ventilation within 3 days of admission, and received any sedative drug (dexmedetomidine, midazolam, or propofol). One-to-one propensity score matching was performed between patients who received dexmedetomidine on the day of mechanical ventilation initiation (dexmedetomidine group) and those who did not receive dexmedetomidine (control group). The primary outcome was all-cause 30-day in-hospital mortality. Secondary outcomes were length of hospital stay and duration of mechanical ventilation in patients and survivors. Eligible patients (n = 1888) were cla...Continue Reading

References

Oct 1, 1974·Annals of Surgery·D W WilmoreB A Pruitt
Aug 24, 2000·Epidemiology·J M RobinsB Brumback
Apr 15, 2004·JAMA : the Journal of the American Medical Association·E Wesley ElyRobert S Dittus
Jan 15, 2005·Burns : Journal of the International Society for Burn Injuries·K KobayashiH Nakazawa
Feb 3, 2005·Burns : Journal of the International Society for Burn Injuries·Jean CassutoJohanna Räntfors
Dec 13, 2007·JAMA : the Journal of the American Medical Association·Pratik P PandharipandeE Wesley Ely
Jan 24, 2009·Journal of Burn Care & Research : Official Publication of the American Burn Association·Rachel S LundgrenMatthew B Klein
Mar 18, 2010·Critical Care : the Official Journal of the Critical Care Forum·Pratik P PandharipandeUNKNOWN MENDS investigators
Sep 24, 2011·Burns : Journal of the International Society for Burn Injuries·N N SheppardP Dziewulski
Mar 23, 2012·JAMA : the Journal of the American Medical Association·Stephan M JakobUNKNOWN Dexmedetomidine for Long-Term Sedation Investigators
Apr 25, 2012·Intensive Care Medicine·Christian A SchmittingerMartin W Dünser
Nov 14, 2012·Journal of Burn Care & Research : Official Publication of the American Burn Association·Alice FaginSoman Sen
Mar 8, 2013·Burns : Journal of the International Society for Burn Injuries·Sven AsmussenMarc O Maybauer
Jul 19, 2013·Critical Care Medicine·Yahya ShehabiUNKNOWN Australian and New Zealand Intensive Care Society Clinical Trials Group
Aug 1, 2013·Health Services Management Research : an Official Journal of the Association of University Programs in Health Administration·James TiessenCharles McMillan
Jun 30, 2015·Burns : Journal of the International Society for Burn Injuries·Takashi TagamiHideo Yasunaga
Sep 26, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Takashi TagamiHideo Yasunaga
Mar 23, 2017·JAMA : the Journal of the American Medical Association·Yu KawazoeUNKNOWN Dexmedetomidine for Sepsis in Intensive Care Unit Randomized Evaluation (DESIRE) Trial Investigators
May 26, 2017·The Journal of Trauma and Acute Care Surgery·Stephanie A MasonMarc G Jeschke
Jul 8, 2018·Burns : Journal of the International Society for Burn Injuries·Asuka TsuchiyaHideo Yasunaga
Dec 13, 2019·Critical Care : the Official Journal of the Critical Care Forum·Charles A FlandersTimothy S Walsh
Dec 14, 2019·Critical Care : the Official Journal of the Critical Care Forum·Mikio NakajimaHideo Yasunaga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
Punkaj GuptaStephen J Roth
Saudi Journal of Anaesthesia
Om Prakash SanjeevPrakash Kumar Dubey
© 2021 Meta ULC. All rights reserved